PHARMACIST INTERVENTIONS IN ACUTE CORONARY SYNDROME: IMPROVING MEDICATION SAFETY

Mohana Sindu S1*, Komali K1, Kavya A1, Srikanth P1, Nagaraju M
Pharm.D Intern, Department of Pharmacy Practice, KLR Pharmacy College, Paloncha, Telangana, India.

Acute Coronary Syndrome, Clinical Pharmacist, Medication Safety, Pharmacist Interventions, Cardiovascular Pharmacotherapy ,

Acute Coronary Syndrome (ACS) is one of the health issues in the world that have been linked to a high level of morbidity and mortality. It includes a continuum of clinical syndromes, such as unstable angina, non-ST-elevation myocardial infarction (NSTEMI) and ST-elevation myocardial infarction (STEMI), which are caused by abrupt coronary blood flow deficit. ACS needs to be managed by means of timely pharmacotherapy, timely diagnosis, and multidisciplinary management. The ACS treatment with various drug classes including antiplatelets, anticoagulants, beta blockers, statins, and nitrates, however, adds the risk of medication-related issues, dosing errors, adverse drug reactions, and drug-drug interaction. Medication safety can be enhanced by clinical pharmacists using various interventions to enhance medication safety, including medication review, reconciliation, and dose optimization, monitoring drug interactions, and counseling patients. Interaction in multidisciplinary groups increases compliance with evidence-based therapy and increases the results of the treatment process. Pharmacist-based interventions have been found to decrease medication errors, enhance treatment compliance, and hospital readmissions and, therefore, lead to safer and more efficient treatment of ACS patients.

16 , 2 , 2026